Dr Charles Kenneth Bergdolt, DO in Fallon, NV - Preventive Medicine

Dr Charles Kenneth Bergdolt, DO is a Preventive Medicine - Aerospace Medicine physician based in Fallon, Nevada. Dr Charles Kenneth Bergdolt is licensed to practice in Idaho (license number O-1734) and his current practice location is 4755 Pasture Rd, Fallon, Nevada. He can be reached at his office (for appointments etc.) via phone at (904) 542-7300.

NPI number for Dr Charles Kenneth Bergdolt is 1194392241 and his current mailing address is 4755 Pasture Rd, Fallon, Nevada. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1194392241.

Contact Information

	Dr Charles Kenneth Bergdolt, DO
	4755 Pasture Rd, Fallon, NV 89406-3491
	(904) 542-7300
	Not Available

Physician's Profile

Full Name	Dr Charles Kenneth Bergdolt
Gender	Male
Speciality	Preventive Medicine - Aerospace Medicine
Location	4755 Pasture Rd, Fallon, Nevada
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1194392241
Provider Enumeration Date: 06/08/2021
Last Update Date: 07/10/2023

Medical Identifiers

Medical identifiers for Dr Charles Kenneth Bergdolt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194392241	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	8288488 (Alabama)	Secondary
2083A0100X	Preventive Medicine - Aerospace Medicine	O-1734 (Idaho)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Charles Kenneth Bergdolt is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Charles Kenneth Bergdolt, DO 4755 Pasture Rd, Fallon, NV 89406-3491 Ph: (334) 224-8053	Dr Charles Kenneth Bergdolt, DO 4755 Pasture Rd, Fallon, NV 89406-3491 Ph: (904) 542-7300

News Archive

Tocopherol derivatives as new dioxin receptor antagonists

When reactive oxygen species (ROS) hit the body, vitamin E helps to prevent damage to tissues and cells by acting as an antioxidant. The health benefits of vitamin E are numerous, and in fact, studies have found that people with higher levels of vitamin E in their system have a lower risk of heart disease and certain forms of cancer. A team led by Thomas Rosenau from the University of Natural Resources and Life Sciences in Vienna (Austria) now describe their synthesis of a series of modified vitamin E derivatives that show promise as dioxin receptor antagonists in the European Journal of Organic Chemistry.

Surgical masks effectively reduce outgoing airborne particles, despite leakage at edges

A new study from the University of California, Davis and the Icahn School of Medicine at Mount Sinai confirms that surgical masks effectively reduce outgoing airborne particles from talking or coughing, even after allowing for leakage around the edges of the mask. The results are published June 8 in Scientific Reports.

FDA has warned consumers not to purchase or to consume Actra-Rx or Yilishen, promoted as "dietary supplements" for treating erectile dysfunction

The Food and Drug Administration today warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

Drug delivery system that consists of nanocrystals of a hydrophobic drug

The problem of efficiently delivering drugs, especially those that are hydrophobic or water-repellant, to tumors or other disease sites has long challenged scientists to develop innovative delivery systems that keep these drugs intact until reaching their targets.

AP/Washington Post examines experimental malaria vaccine, mutant mosquitoes to combat malaria

During the 1990s, Sanaria CEO Stephen Hoffman "irradiated malaria-carrying mosquitoes to weaken the parasites inside them, and he and 13 colleagues subjected themselves to more than 1,000 bites," according to the AP/Washington Post.

Dr Charles Kenneth Bergdolt, DO - Preventive Medicine in Fallon, NV